Patents by Inventor Naoki Goshima

Naoki Goshima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190078053
    Abstract: Provided is a method of inducing cardiac progenitor cells or cardiomyocytes from pluripotent stem cells. The present invention provides a method for producing cardiac progenitor cells from pluripotent stem cells, comprising expressing Tbx6 in the pluripotent stem cells. Moreover, the present invention provides a method for producing cardiomyocytes from pluripotent stem cells, comprising: a step of inducing cardiac progenitor cells from pluripotent stem cells, comprising expressing a Tbx6 gene in the pluripotent stem cells; and a step of inducing cardiomyocytes from the cardiac progenitor cells induced in the above step, comprising suppressing the expression of the Tbx6 gene.
    Type: Application
    Filed: March 7, 2017
    Publication date: March 14, 2019
    Applicants: Keio University, National Institute of Advanced Industrial Science and Technology
    Inventors: Masaki IEDA, Taketaro SADAHIRO, Mari ISOMI, Naoki GOSHIMA
  • Publication number: 20190071641
    Abstract: Provided is a method of inducing cardiac progenitor cells or cardiomyocytes from fibroblasts. The present invention provides a method for producing cardiac progenitor cells, comprising introducing one cardiac reprogramming factor into fibroblasts, or a method for producing cardiomyocytes, comprising introducing three cardiac reprogramming factors into fibroblasts.
    Type: Application
    Filed: March 7, 2017
    Publication date: March 7, 2019
    Applicants: Keio University, National Institute of Advanced Industrial Science and Technology
    Inventors: Masaki IEDA, Taketaro SADAHIRO, Mari ISOMI, Naoki GOSHIMA
  • Patent number: 9890360
    Abstract: A method that includes bringing a nuclear reprogramming substance (DLX4 gene, OCT3/4 gene, and SOX2 gene) into contact with a cell and thereby producing iPS cells.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: February 13, 2018
    Assignees: GIFU UNIVERSITY, NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    Inventors: Kenichi Tezuka, Naritaka Tamaoki, Kazuki Iida, Tomoko Kawaguchi, Hitomi Aoki, Takahiro Kunisada, Toshiyuki Shibata, Naoki Goshima
  • Patent number: 9751922
    Abstract: A technology which enables a high yield and convenient recovery of a protein and also enables a global protein purification is provided. A protein tag comprising an amino acid sequence of the full length or a part of MafG protein or an amino acid sequence in which amino acids serving as protease cleavage sites were inserted into the former amino acid sequence is provided. Since this protein tag can impart a high insolubility attributable to MafG protein to a protein to be tagged thereby insolubilizing the tagged protein, the tagged protein can be recovered into an insoluble fraction at a high yield.
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: September 5, 2017
    Assignee: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    Inventors: Naoki Goshima, Eriko Fukuda, Masatoshi Mori
  • Publication number: 20160208218
    Abstract: A method that includes bringing a nuclear reprogramming substance (DLX4 gene, OCT3/4 gene, and SOX2 gene) into contact with a cell and thereby producing iPS cells.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 21, 2016
    Applicants: GIFU UNIVERSITY, NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    Inventors: Kenichi TEZUKA, Naritaka TAMAOKI, Kazuki IIDA, Tomoko KAWAGUCHI, Hitomi AOKI, Takahiro KUNISADA, Toshiyuki SHIBATA, Naoki GOSHIMA
  • Publication number: 20150166619
    Abstract: A technology which enables a high yield and convenient recovery of a protein and also enables a global protein purification is provided. A protein tag comprising an amino acid sequence of the full length or a part of MafG protein or an amino acid sequence in which amino acids serving as protease cleavage sites were inserted into the former amino acid sequence is provided. Since this protein tag can impart a high insolubility attributable to MafG protein to a protein to be tagged thereby insolubilizing the tagged protein, the tagged protein can be recovered into an insoluble fraction at a high yield.
    Type: Application
    Filed: November 21, 2012
    Publication date: June 18, 2015
    Applicant: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    Inventors: Naoki Goshima, Eriko Fukuda, Masatoshi Mori
  • Patent number: 8951801
    Abstract: Reprogramming substances capable of substituting for Klf4, selected from the group consisting of members of the IRX family (e.g., IRX6), members of the GLIS family (e.g., GLIS1), members of the PTX family (e.g., PITX2), DMRTB1, and nucleic acids that encode the same, are provided. Also provided are a method of producing iPS cells, comprising the step of introducing into a somatic cell both one or more kinds of the above-described nuclear reprogramming substances and a substance capable of inducing iPS cells from a somatic cell when combined with Klf4. Still also provided are iPS cells comprising an extraneous nucleic acid that encodes any one of the above-described nuclear reprogramming substances, that can be obtained by the method, and a method of producing somatic cells by inducing the iPS cells to differentiate.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: February 10, 2015
    Assignees: Kyoto University, National Institute of Advanced Industrial Science and Technology, Japan Biological Informatics Consortium
    Inventors: Shinya Yamanaka, Naoki Goshima, Momoko Maekawa, Yoshifumi Kawamura, Hiromi Mochizuki
  • Patent number: 8927277
    Abstract: Provided are a method of improving the efficiency of establishment of iPS cells, comprising the step of contacting one or more substances selected from the group consisting of members of the GLIS family (e.g., GLIS1) and nucleic acids that encode the same and one or more substances selected from the group consisting of members of the Klf family and nucleic acids that encode the same, with a somatic cell, an iPS cell comprising an exogenous nucleic acid that encodes a member of the GLIS family or a member of the Klf family, that can be obtained by the method, and a method of producing a somatic cell by inducing the differentiation of the iPS cell.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: January 6, 2015
    Assignees: Kyoto University, National Institute of Advanced Industrial Science and Technology, Japan Biological Informatics Consortium
    Inventors: Shinya Yamanaka, Naoki Goshima, Momoko Maekawa, Yoshifumi Kawamura, Hiromi Mochizuki
  • Publication number: 20130029423
    Abstract: Provided are a method of improving the efficiency of establishment of iPS cells, comprising the step of contacting one or more substances selected from the group consisting of members of the GLIS family (e.g., GLIS1) and nucleic acids that encode the same and one or more substances selected from the group consisting of members of the Klf family and nucleic acids that encode the same, with a somatic cell, an iPS cell comprising an exogenous nucleic acid that encodes a member of the GLIS family or a member of the Klf family, that can be obtained by the method, and a method of producing a somatic cell by inducing the differentiation of the iPS cell.
    Type: Application
    Filed: February 16, 2011
    Publication date: January 31, 2013
    Applicants: Kyoto University, Japan Biological Informatics Consortium, National Institute of Advanced Industrial Science and Technology
    Inventors: Shinya Yamanaka, Naoki Goshima, Momoko Maekawa, Yoshifumi Kawamura, Hiromi Mochizuki
  • Publication number: 20120052583
    Abstract: Reprogramming substances capable of substituting for Klf4, selected from the group consisting of members of the IRX family (e.g., IRX6), members of the GLIS family (e.g., GLIS1), members of the PTX family (e.g., PITX2), DMRTB1, and nucleic acids that encode the same, are provided. Also provided are a method of producing iPS cells, comprising the step of introducing into a somatic cell both one or more kinds of the above-described nuclear reprogramming substances and a substance capable of inducing iPS cells from a somatic cell when combined with Klf4. Still also provided are iPS cells comprising an extraneous nucleic acid that encodes any one of the above-described nuclear reprogramming substances, that can be obtained by the method, and a method of producing somatic cells by inducing the iPS cells to differentiate.
    Type: Application
    Filed: February 19, 2010
    Publication date: March 1, 2012
    Applicants: KYOTO UNIVERSITY, National Institute of Advances Industtrial Science and Technology, JAPAN BIOLOGICAL INFORMATICS CONSORTIUM
    Inventors: Shinya Yamanaka, Naoki Goshima, Momoko Maekawa, Yoshifumi Kawamura, Hiromi Mochizuki
  • Publication number: 20040040053
    Abstract: The present invention provides materials and methods for the rapid cloning and mutagenesis of nucleic acid molecules. The present invention permits simultaneous introduction of a one or more point mutations and adapter sequences into a nucleic acid of interest.
    Type: Application
    Filed: November 22, 2002
    Publication date: February 26, 2004
    Inventors: Nobuo Nomura, Naoki Goshima, Yasutomo Kisu, Saki Sono
  • Patent number: 6630625
    Abstract: A wire harness includes a flat cable having a trunk portion formed by covering a plurality of parallel electric wires with an insulating coating by integral molding, a plurality of branch portions formed by branching the trunk portion, and a joint device for connecting not less than two electric wires of the plurality of electric wires constituting the trunk portion to electrically short-circuit the branch portions.
    Type: Grant
    Filed: March 28, 1995
    Date of Patent: October 7, 2003
    Assignee: Fujikura Limited
    Inventors: Kazuya Akashi, Kazuo Enomoto, Naoki Goshima, Kenichirou Takahashi, Hideki Kawamura, Takeshi Hasegawa, Yasuo Takemura, Hidetaka Yamazaki, Atsushi Hamada